XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 141 participants.

Also called NCT05881278

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 141 participants (planned count) (from the registry)
Sponsor
XVIVO Perfusion (from the registry)
Registry
  • NCT NCT05881278
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05881278. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-10 (actual); primary completion 2025-11-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
Condition
Heart Failure
Condition
Transplant; Failure, Heart
Intervention (Device)
Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS)
Lead sponsor
XVIVO Perfusion (class: industry)

Record details

Record id
cardio:ct-nct05881278
Content hash
d02b83e872ab3c3259c400d340e53938bdba67843b5cc0ae71c3d67934dca689